Your browser doesn't support javascript.
loading
American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update.
Ruggiero, Salvatore L; Dodson, Thomas B; Fantasia, John; Goodday, Reginald; Aghaloo, Tara; Mehrotra, Bhoomi; O'Ryan, Felice.
Affiliation
  • Ruggiero SL; Clinical Professor, Division of Oral and Maxillofacial Surgery, Stony Brook School of Dental Medicine, Hofstra North Shore-LIJ School of Medicine, New York Center for Orthognathic and Maxillofacial Surgery, Lake Success, NY. Electronic address: sruggie@optonline.net.
  • Dodson TB; Professor and Chair, Associate Dean for Hospital Affairs, Department of Oral and Maxillofacial Surgery, University of Washington School of Dentistry, Seattle, WA.
  • Fantasia J; Chief, Division of Oral Pathology, Department of Dental Medicine, Hofstra North Shore-LIJ School of Medicine , New Hyde Park, NY.
  • Goodday R; Professor, Department of Oral and Maxillofacial Sciences, Dalhousie University, Halifax, NS, Canada.
  • Aghaloo T; Associate Professor, Oral and Maxillofacial Surgery, Assistant Dean for Clinical Research, UCLA School of Dentistry, Los Angeles, CA.
  • Mehrotra B; Director, Cancer Institute at St Francis Hospital, Roslyn, NY.
  • O'Ryan F; Director, Division of Maxillofacial Surgery, Kaiser Permanente Oakland Medical Center, Oakland, CA.
J Oral Maxillofac Surg ; 72(10): 1938-56, 2014 Oct.
Article in En | MEDLINE | ID: mdl-25234529
Strategies for management of patients with, or at risk for, medication-related osteonecrosis of the jaw (MRONJ) were set forth in the American Association of Oral and Maxillofacial Surgeons (AAOMS) position papers in 2007 and 2009. The position papers were developed by a special committee appointed by the board and composed of clinicians with extensive experience in caring for these patients and basic science researchers. The knowledge base and experience in addressing MRONJ has expanded, necessitating modifications and refinements to the previous position paper. This special committee met in September 2013 to appraise the current literature and revise the guidelines as indicated to reflect current knowledge in this field. This update contains revisions to diagnosis, staging, and management strategies and highlights current research status. The AAOMS considers it vitally important that this information be disseminated to other relevant health care professionals and organizations.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteonecrosis / Jaw Diseases / Angiogenesis Inhibitors / Bone Density Conservation Agents / Bisphosphonate-Associated Osteonecrosis of the Jaw Type of study: Diagnostic_studies / Etiology_studies / Guideline / Risk_factors_studies Limits: Humans Language: En Journal: J Oral Maxillofac Surg Year: 2014 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteonecrosis / Jaw Diseases / Angiogenesis Inhibitors / Bone Density Conservation Agents / Bisphosphonate-Associated Osteonecrosis of the Jaw Type of study: Diagnostic_studies / Etiology_studies / Guideline / Risk_factors_studies Limits: Humans Language: En Journal: J Oral Maxillofac Surg Year: 2014 Type: Article